PhoenixBio Co., Ltd. (TYO:6190)
Japan · Delayed Price · Currency is JPY 312.00
0.00 (0.00%)
Oct 26, 2026, 12:53 PM JST
PhoenixBio Market Cap
PhoenixBio has a market cap or net worth of 1.27 billion as of October 26, 2026. It is the 42,643rd most valuable company in the world and the 3,835th biggest in Japan. Its market cap has decreased by 37.30% in one year.
Market Cap
1.27B
Enterprise Value
464.90M
Revenue
1.42B
Global Rank
Country Rank
#3,835 Japan
PE Ratio
84.65
ChartMarket Cap Chart
Since March 18, 2016, PhoenixBio's market cap has decreased from 8.06B to 1.27B, a decrease of -84.24%. That is a compound annual growth rate of -15.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 1.27B | -35.54% |
| Dec 30, 2025 | 1.97B | 47.38% |
| Dec 30, 2024 | 1.34B | -23.59% |
| Dec 29, 2023 | 1.75B | -25.42% |
| Dec 30, 2022 | 2.35B | 39.61% |
| Dec 30, 2021 | 1.68B | -13.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kohjin Bio | 3.92B |
| Chordia Therapeutics | 3.86B |
| Noile-Immune Biotech | 3.82B |
| Ribomic | 3.73B |
| D. Western Therapeutics Institute | 3.68B |
| Transgenic Group | 3.45B |
| Human Metabolome Technologies | 3.28B |
| Modalis Therapeutics | 2.98B |